Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance Arteries

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
HypertensionDiabetes
Interventions
DRUG

Aliskiren vs. hydrochlorothiazide

Aliskiren will be used at increasing doses from 150 to 300 mg per day for 6-12 months.

DRUG

Hydrochlorothiazide

Hydrochlorothiazide will be used at increasing doses from 12.5 to 25 mg per day for 6-12 months.

Trial Locations (1)

H3T 1E2

Cardiovascular Prevention Centre, Jewish General Hospital, Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Sir Mortimer B. Davis - Jewish General Hospital

OTHER